ZFT-15679-51505
3 vaccinations
5 coded responses
22 check-ins
5 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 973 / OR
- Registered
- 2021-01-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-21
Dose 1 — Moderna
-
2021-01-27
Registered in v-safe
-
2021-01-27
Survey response — days 1–6 daily, dose 1MedDRA: Erythema, Pain, Pruritus, Rash — Feeling: Good · Site: Pain · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: On the fifth day, I experienced rash redness pain and itching. It lasted about an hour and a half and slowly dissipated.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-27
Report sent to call center — days 1–6 daily, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-01-28
-
2021-02-04
Survey response — day 14, dose 1MedDRA: Chills, Rash, Rash pruritic, Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: On 31 January I experienced my second possible reaction to the first vaccination. I broke out in a rash with itching and cold chills. It lasted an hour and a half to two hours · Healthcare visit (other): Just reported this second incident through my doctors portalMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Report sent to call center — day 14, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-02-11
- 2021-02-18
-
2021-02-24
Dose 2 — Moderna
- 2021-02-24
-
2021-02-25
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-01
-
2021-03-02
Survey response — days 1–6 daily, dose 2MedDRA: Erythema, Pruritus, Swelling face — Feeling: Fair · Chills, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: Itching on feet and joints. Swelling and redness on face, joints and feetMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-03
- 2021-03-10
- 2021-03-17
-
2021-03-24
Survey response — day 28, dose 2MedDRA: Erythema, Swelling — Feeling: Fair · Be unable to do your normal daily activitiesFree text: This is the fourth episode of swelling and redness. It was from head to toe this time and lasted approximately two hours as did the other three episodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-31
- 2021-04-07
- 2021-04-13
- 2021-05-26
- 2021-06-29
- 2021-08-27
-
2021-10-29
Dose 3 — Janssen/Johnson & Johnson
-
2022-02-24
Survey response — 12 months, dose 2MedDRA: Adverse reaction, Office visit — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: I just want to take this opportunity to let you know that after 2 Moderno vaccinations and having 5 adverse reactions, I was advised by my physician to receive a J&J booster. I had no adverse reactions from this booster.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-24
Report sent to call center — 12 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-25
- 2022-04-18
- 2022-04-19
-
2022-04-19
Call successfulDoes not wish to fill out VAERS report
- 2022-10-29
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-21 | Moderna | |
| 2 | 2021-02-24 | Moderna | |
| 3 | 2021-10-29 | Janssen/Johnson & Johnson | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-27 | Successful | Does not wish to fill out VAERS report |
| 2021-02-04 | Successful | Does not wish to fill out VAERS report |
| 2022-02-24 | Successful 2022-04-19 |
Does not wish to fill out VAERS report |
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): On the fifth day, I experienced rash redness pain and itching. It lasted about an hour and a half and slowly dissipated.
Release 3 — day 14, dose 1
Symptoms: On 31 January I experienced my second possible reaction to the first vaccination. I broke out in a rash with itching and cold chills. It lasted an hour and a half to two hours
Healthcare visit (other): Just reported this second incident through my doctors portal
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Itching on feet and joints. Swelling and redness on face, joints and feet
Release 6 — day 28, dose 2
Symptoms: This is the fourth episode of swelling and redness. It was from head to toe this time and lasted approximately two hours as did the other three episodes
Release 11 — 12 months, dose 2
Symptoms: I just want to take this opportunity to let you know that after 2 Moderno vaccinations and having 5 adverse reactions, I was advised by my physician to receive a J&J booster. I had no adverse reactions from this booster.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Unevaluable event | ✓ | ✓ | ✓ |
| SD | Adverse reaction | · | · | ✓ |
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Erythema | ✓ | ✓ | ✓ |
| SD | Office visit | · | · | ✓ |
| SD | Rash | ✓ | ✓ | ✓ |
| SD | Rash pruritic | ✓ | ✓ | ✓ |
| SD | Swelling | ✓ | ✓ | ✓ |
| SRO | Erythema | ✓ | ✓ | ✓ |
| SRO | Pain | ✓ | ✓ | ✓ |
| SRO | Pruritus | ✓ | ✓ | ✓ |
| SRO | Rash | ✓ | ✓ | ✓ |
| SRO | Swelling face | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release